Fangzhou Completes HK$150 Million Top-up Placement

MT Newswires Live02-03

Fangzhou (HKG:6086) said it completed a HK$150 million top-up placement, according to a Hong Kong bourse filing Monday.

Shares of the online chronic disease management platform gained over 16% in morning trade Tuesday.

Celaeno Group, the firm's controlling shareholder, sold its 45.2 million shares in Fangzhou at HK$3.32 apiece. Fangzhou then issued new shares to Celaeno, which agreed to subscribe for the equivalent number of shares it sold at the same price.

Fangzhou previously said about 90% of the net proceeds will be used to accelerate development of its AI-driven chronic disease management platform, with the remaining 10% allocated to working capital and general corporate purposes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment